This is a StreetInsider.com Premium Only Page

Opiant Pharmaceuticals (OPNT) –

Jul 11, 2023 04:32 PM Form CT ORDER OPIANT PHARMACEUTICALS,

Mar 13, 2023 06:16 AM Form 15-12G OPIANT PHARMACEUTICALS,

Mar 10, 2023 06:06 AM Form EFFECT OPIANT PHARMACEUTICALS,

Mar 10, 2023 06:06 AM Form EFFECT OPIANT PHARMACEUTICALS,

Mar 10, 2023 06:05 AM Form EFFECT OPIANT PHARMACEUTICALS,

Mar 6, 2023 02:07 PM Form POS AM OPIANT PHARMACEUTICALS,

Mar 6, 2023 02:02 PM Form POS AM OPIANT PHARMACEUTICALS,

Mar 6, 2023 01:56 PM Form POS AM OPIANT PHARMACEUTICALS,

Mar 6, 2023 01:17 PM Form S-8 POS OPIANT PHARMACEUTICALS,

Mar 6, 2023 01:14 PM Form S-8 POS OPIANT PHARMACEUTICALS,

Mar 6, 2023 01:10 PM Form S-8 POS OPIANT PHARMACEUTICALS,

Mar 6, 2023 01:07 PM Form S-8 POS OPIANT PHARMACEUTICALS,

Mar 6, 2023 01:02 PM Form S-8 POS OPIANT PHARMACEUTICALS,

Mar 6, 2023 12:57 PM Form S-8 POS OPIANT PHARMACEUTICALS,

Mar 3, 2023 09:27 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Silver Gabrielle Alison

Mar 3, 2023 09:25 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Collard Craig A

Mar 3, 2023 09:23 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Ruth Matthew R.

Mar 3, 2023 09:21 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Daly Richard J

Mar 3, 2023 09:20 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: CRYSTAL ROGER

Mar 3, 2023 09:17 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Ellison Mark Jason Heath

Mar 3, 2023 09:13 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Skolnick Phil

Mar 3, 2023 09:11 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Sinclair Michael

Mar 3, 2023 09:09 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: MacDougall Ann L.

Mar 3, 2023 09:06 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Lorianne Masuoka K.

Mar 3, 2023 09:03 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Gorman Brian

Mar 3, 2023 09:00 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: Thomas Thomas T.

Mar 3, 2023 08:57 AM Form 4 OPIANT PHARMACEUTICALS, For: Mar 02 Filed by: O'Toole David D

Mar 2, 2023 09:46 AM Form 25-NSE OPIANT PHARMACEUTICALS, Filed by: Nasdaq Stock Market LLC

Mar 2, 2023 09:21 AM Form 8-K OPIANT PHARMACEUTICALS, For: Mar 02

Mar 1, 2023 04:15 PM Form 8-K OPIANT PHARMACEUTICALS, For: Mar 01

Feb 27, 2023 04:04 PM Form 8-K OPIANT PHARMACEUTICALS, For: Feb 23

Feb 22, 2023 04:05 PM Form DEFA14A OPIANT PHARMACEUTICALS,

Feb 21, 2023 10:00 AM Deepwatch Names Mel Wesley as Chief Financial Officer

Feb 16, 2023 05:14 PM Form DFAN14A OPIANT PHARMACEUTICALS, Filed by: INDIVIOR PLC

Feb 15, 2023 01:20 PM Form SC 13G/A OPIANT PHARMACEUTICALS, Filed by: Western Standard LLC

Feb 7, 2023 04:49 PM Form DEFA14A OPIANT PHARMACEUTICALS,

Feb 7, 2023 04:27 PM Form 8-K OPIANT PHARMACEUTICALS, For: Feb 02

Feb 7, 2023 04:02 PM Opiant Pharmaceuticals (OPNT) Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

Feb 7, 2023 04:01 PM Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

Feb 7, 2023 04:01 PM Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

Feb 6, 2023 12:14 PM Form DFAN14A OPIANT PHARMACEUTICALS, Filed by: INDIVIOR PLC

Feb 6, 2023 08:00 AM Opiant Pharmaceuticals (OPNT) Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC

Feb 6, 2023 08:00 AM Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC

Feb 6, 2023 08:00 AM Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC

Jan 31, 2023 04:23 PM Form 4 OPIANT PHARMACEUTICALS, For: Jan 27 Filed by: CRYSTAL ROGER

Jan 31, 2023 04:22 PM Form 4 OPIANT PHARMACEUTICALS, For: Jan 27 Filed by: Ellison Mark Jason Heath

Jan 31, 2023 04:20 PM Form 4 OPIANT PHARMACEUTICALS, For: Jan 27 Filed by: Gorman Brian

Jan 31, 2023 04:20 PM Form 4 OPIANT PHARMACEUTICALS, For: Jan 27 Filed by: Skolnick Phil

Jan 31, 2023 04:17 PM Form 4 OPIANT PHARMACEUTICALS, For: Jan 27 Filed by: O'Toole David D

Jan 19, 2023 04:05 PM Opiant Pharmaceuticals (OPNT) Announces FDA Acceptance and Priority Review of NDA for OPNT003